Karuna Therapeutics NASDAQ:KRTX 03/18/24- Company acquired by BMY. Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.Karuna understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing itsextensive knowledge of neuroscience, the Company is harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives.

Location: | Website: karunatx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing